- Home
- ACGLO vs GALT Comparison
ACGLO vs GALT Comparison
Compare ACGLO & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACGLO
- GALT
- Stock Information
- Founded
- ACGLO N/A
- GALT 2000
- Country
- ACGLO Bermuda
- GALT United States
- Employees
- ACGLO 5800
- GALT N/A
- Industry
- ACGLO Property-Casualty Insurers
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- ACGLO Finance
- GALT Health Care
- Exchange
- ACGLO Nasdaq
- GALT Nasdaq
- Market Cap
- ACGLO N/A
- GALT 83.5M
- IPO Year
- ACGLO N/A
- GALT N/A
- Fundamental
- Price
- ACGLO $20.70
- GALT $2.18
- Analyst Decision
- ACGLO
- GALT Buy
- Analyst Count
- ACGLO 0
- GALT 2
- Target Price
- ACGLO N/A
- GALT $6.00
- AVG Volume (30 Days)
- ACGLO N/A
- GALT 1.4M
- Earning Date
- ACGLO N/A
- GALT 08-12-2025
- Dividend Yield
- ACGLO N/A
- GALT N/A
- EPS Growth
- ACGLO N/A
- GALT N/A
- EPS
- ACGLO N/A
- GALT N/A
- Revenue
- ACGLO N/A
- GALT N/A
- Revenue This Year
- ACGLO N/A
- GALT N/A
- Revenue Next Year
- ACGLO N/A
- GALT N/A
- P/E Ratio
- ACGLO N/A
- GALT N/A
- Revenue Growth
- ACGLO N/A
- GALT N/A
- 52 Week Low
- ACGLO N/A
- GALT $0.73
- 52 Week High
- ACGLO N/A
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- ACGLO 58.63
- GALT 56.30
- Support Level
- ACGLO $20.39
- GALT $2.08
- Resistance Level
- ACGLO $20.80
- GALT $2.66
- Average True Range (ATR)
- ACGLO 0.20
- GALT 0.53
- MACD
- ACGLO 0.04
- GALT -0.02
- Stochastic Oscillator
- ACGLO 86.49
- GALT 33.07
About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.